How much revenue did Covetrus generate this year?
Covetrus has achieved a revenue of 5.56 B USD this year.
Covetrus Revenue 2024
Covetrus Revenue
5.56 B USD
Ticker
CVET
ISIN
US22304C1009
WKN
A2PBX0
In 2024, Covetrus's sales reached 5.56 B USD, a 6.05% difference from the 5.24 B USD sales recorded in the previous year.
The Covetrus Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 6.14 | 13,96 |
| 2025e | 5.79 | 14,83 |
| 2024e | 5.56 | 15,43 |
| 2023e | 5.24 | 16,36 |
| 2022e | 4.93 | 17,39 |
| 2021 | 4.58 | 18,75 |
| 2020 | 4.34 | 18,39 |
| 2019 | 3.98 | 18,84 |
| 2018 | 3.78 | 18,11 |
| 2017 | 3.58 | 18,21 |
| 2016 | 3.35 | 18,49 |
| 2015 | 2.98 | 17,80 |
Covetrus Revenue, EBIT, Net Income US22304C1009 · A2PBX0
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Covetrus, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Covetrus from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Covetrus’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Covetrus. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Covetrus’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Covetrus’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Covetrus’s growth potential.
Covetrus Revenue, EBIT and net profit per share
| Date | Covetrus Revenue | Covetrus EBIT | Covetrus Net Income |
|---|---|---|---|
| 2026e | 6.14 B undefined | 372.89 M undefined | 248.53 M undefined |
| 2025e | 5.79 B undefined | 332.25 M undefined | 219.54 M undefined |
| 2024e | 5.56 B undefined | 301.96 M undefined | 197.81 M undefined |
| 2023e | 5.24 B undefined | 274.14 M undefined | 175.8 M undefined |
| 2022e | 4.93 B undefined | 239.81 M undefined | 154.36 M undefined |
| 2021 | 4.58 B undefined | -23 M undefined | -54 M undefined |
| 2020 | 4.34 B undefined | -69 M undefined | -19 M undefined |
| 2019 | 3.98 B undefined | -59 M undefined | -980 M undefined |
| 2018 | 3.78 B undefined | 145.6 M undefined | 100.9 M undefined |
| 2017 | 3.58 B undefined | 135.3 M undefined | 64.4 M undefined |
| 2016 | 3.35 B undefined | 131.1 M undefined | 70.3 M undefined |
| 2015 | 2.98 B undefined | 112.1 M undefined | 60.3 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2015 | 2.98 B USD | 112.1 M USD | 60.3 M USD |
| 2016 | 3.35 B USD | 131.1 M USD | 70.3 M USD |
| 2017 | 3.58 B USD | 135.3 M USD | 64.4 M USD |
| 2018 | 3.78 B USD | 145.6 M USD | 100.9 M USD |
| 2019 | 3.98 B USD | -59 M USD | -980 M USD |
| 2020 | 4.34 B USD | -69 M USD | -19 M USD |
| 2021 | 4.58 B USD | -23 M USD | -54 M USD |
| 2022e | 4.93 B USD | 239.81 M USD | 154.36 M USD |
| 2023e | 5.24 B USD | 274.14 M USD | 175.8 M USD |
| 2024e | 5.56 B USD | 301.96 M USD | 197.81 M USD |
| 2025e | 5.79 B USD | 332.25 M USD | 219.54 M USD |
| 2026e | 6.14 B USD | 372.89 M USD | 248.53 M USD |
Covetrus stock margins US22304C1009 · A2PBX0
The Covetrus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Covetrus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Covetrus.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Covetrus's sales revenue. A higher gross margin percentage indicates that the Covetrus retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Covetrus's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Covetrus's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Covetrus's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Covetrus. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Covetrus's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Covetrus Margin History
| Covetrus Gross margin | Covetrus Profit margin | Covetrus EBIT margin | Covetrus Profit margin |
|---|---|---|---|
| 2026e | 18.75 % | 6.07 % | 4.04 % |
| 2025e | 18.75 % | 5.74 % | 3.79 % |
| 2024e | 18.75 % | 5.43 % | 3.56 % |
| 2023e | 18.75 % | 5.23 % | 3.35 % |
| 2022e | 18.75 % | 4.86 % | 3.13 % |
| 2021 | 18.75 % | -0.5 % | -1.18 % |
| 2020 | 18.39 % | -1.59 % | -0.44 % |
| 2019 | 18.84 % | -1.48 % | -24.65 % |
| 2018 | 18.11 % | 3.85 % | 2.67 % |
| 2017 | 18.21 % | 3.78 % | 1.8 % |
| 2016 | 18.49 % | 3.91 % | 2.1 % |
| 2015 | 17.8 % | 3.76 % | 2.02 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2015 | 17.8 % | 3.76 % | 2.02 % |
| 2016 | 18.49 % | 3.91 % | 2.1 % |
| 2017 | 18.21 % | 3.78 % | 1.8 % |
| 2018 | 18.11 % | 3.85 % | 2.67 % |
| 2019 | 18.84 % | -1.48 % | -24.65 % |
| 2020 | 18.39 % | -1.59 % | -0.44 % |
| 2021 | 18.75 % | -0.5 % | -1.18 % |
| 2022e | 18.75 % | 4.86 % | 3.13 % |
| 2023e | 18.75 % | 5.23 % | 3.35 % |
| 2024e | 18.75 % | 5.43 % | 3.56 % |
| 2025e | 18.75 % | 5.74 % | 3.79 % |
| 2026e | 18.75 % | 6.07 % | 4.04 % |
Covetrus Aktienanalyse
What does Covetrus do?
Covetrus Inc is a global company specializing in providing services and products for veterinarians, animal clinics, and pet owners. It was formed in 2019 through a merger between the animal health divisions of Henry Schein and Vets First Choice. Covetrus traces its history back to 1856 when Henry Schein was founded as a small wholesale drug company. Over the years, the company expanded into new industries and markets. In the 2000s, Henry Schein began serving the animal health industry and established Vets First Choice in 2010 to offer a wider range of services and products to veterinarians and animal clinics. With the merger of Vets First Choice and Henry Schein's animal health division in 2019, Covetrus was created as a company with a broad spectrum of products and services for the animal health industry. Covetrus is headquartered in Portland, Maine, USA, and operates in over 25 countries. Its business model is based on providing services and products for veterinarians, animal clinics, and pet owners. The company is divided into several business segments, including diagnostics, pharmaceuticals, and consumables. In the diagnostics area, Covetrus offers a wide range of laboratory diagnostic services for veterinarians, including blood tests, imaging, fecal tests, and genetic tests. These test results help veterinarians diagnose and treat diseases in pets. In the pharmaceutical area, Covetrus offers veterinary medicines for various types of pets, including dogs, cats, and horses. These medicines are developed by leading pharmaceutical companies, and Covetrus provides veterinarians with a reliable supply chain for these products. The most recent business segment of Covetrus is the consumables area. Here, the company offers a wide range of products for veterinarians and animal clinics, including medical devices, surgical instruments, consumables for routine examinations, and more. In addition to these three main business segments, Covetrus also offers a variety of services, including practice management systems, training for veterinarians and animal clinics, financial services, and more. These services are designed to help veterinarians and animal clinics optimize their operations and improve their quality. The company has also developed a mobile application called 'Covetrus Connect' which provides veterinarians and animal clinics with an easier way to access products and services, place orders, and manage their operations. Overall, Covetrus is an innovative and rapidly growing company in the animal health industry. With a wide range of products and services tailored to the needs of veterinarians, animal clinics, and pet owners, the company is well-positioned to continue growing in this emerging market. Covetrus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Covetrus's Sales Figures
The sales figures of Covetrus originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Covetrus’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Covetrus's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Covetrus’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Covetrus stock
How much was the turnover of the company Covetrus compared to the previous year?
The revenue of Covetrus has increased by 6.05% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Covetrus?
The revenue of Covetrus is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Covetrus measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Covetrus so important for investors?
The revenue of Covetrus is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Covetrus pay?
Over the past 12 months, Covetrus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Covetrus is expected to pay a dividend of 0 USD.
What is the dividend yield of Covetrus?
The current dividend yield of Covetrus is .
When does Covetrus pay dividends?
Covetrus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Covetrus?
Covetrus paid dividends every year for the past 0 years.
What is the dividend of Covetrus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Covetrus located?
Covetrus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Covetrus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Covetrus from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did Covetrus pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of Covetrus in the year 2023?
In the year 2023, Covetrus distributed 0 USD as dividends.
In which currency does Covetrus pay out the dividend?
The dividends of Covetrus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Covetrus
Our stock analysis for Covetrus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Covetrus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
